Clinical Trial Update: Leucovorin and Fluorouracil With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Clinical trial update on a Phase 3 study comparing leucovorin and fluorouracil with versus without SU5416 in metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• SU5416 (semaxanib)

Snippet

Sponsor: Pfizer | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED